Chronic essential and secondary hypertension in pregnancy

Bailliere's Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 13, Issue 1, 1999, Pages 115-130

  Gallery, Eileen D M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antihypertensive drugs; Hypertension; Phaeochromocytoma; Pre conception counselling; Pregnancy; Primary hyperaldosteronism; Renal disease; Renovascular disease

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIAZOXIDE; HYDRALAZINE; LABETALOL; NIFEDIPINE; NITROPRUSSIDE SODIUM;

BRADYCARDIA; DELIVERY; DOCTOR PATIENT RELATION; DRUG TOXICITY; ESSENTIAL HYPERTENSION; FEMALE; FETUS DISEASE; HOSPITAL ADMISSION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MATERNAL HYPERTENSION; OBSTETRIC CARE; ORAL DRUG ADMINISTRATION; PHYSICIAN; PREGNANCY DISORDER; PRENATAL CARE; PRIMIGRAVIDA; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK FACTOR; SUBLINGUAL DRUG ADMINISTRATION;

ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; KIDNEY FAILURE, CHRONIC; PHEOCHROMOCYTOMA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PRENATAL CARE;

EID: 0032708948     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.1999.0010     Document Type: Article

References (49)

1. Anastos K, Charney P, Charon RA et al (1991) Hypertension in women: what is really known? Annals of Internal Medicine 115: 287-293.
2. Arias F & Zamora S (1979) Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstetrics and Gynecology 53: 389-393.
3. Barr PA & Gallery EDM (1981) Effect of diazoxide on the antepartum cardiotocograph in severe pregnancy-associated hypertension. Australian and New Zealand Journal of Obstetrics and Gynaecology 21 : 11-15.
4. Belfort MA, Saade GR, Moise KJ Jr et al (1994) Nimodipine in the management of pre-eclampsia: maternal and fetal effects. American Journal of Obstetrics and Gynecology 171:417-424.
5. *Brown MA, Gallery EDM, Gatt S et al (ASSHP Working Party) (1993) Management of hypertension in pregnancy. Summary of consensus statement of Australasian Society for the Study of Hypertension in Pregnancy. Medical Journal of Australia 158: 700-702.
6. Browne FJ & Dodds GH (1942) Pregnancy in the patient with chronic hypertension. Journal of Obstetrics and Gynaecology of the British Empire 49: 1-11.
7. Check JH, Caro JF, Kendall B et al (1979) Cushing's syndrome in pregnancy: effect of associated diabetes on fetal and neonatal complications. American Journal of Obstetrics and Gynecology 133: 846-847.
8. *Chesley LC & Annitto JE (1947) Pregnancy in the patient with hypertensive disease. American Journal of Obstetrics and Gynecology 53: 372-381.
9. Chesley LC & Sloan DM (1964) The effect of posture on renal function in late pregnancy. American Journal of Obstetrics and Gynecology 89: 754-758.
10. Collins R, Peto R, MacMahon S et al (1990) Blood pressure, stroke and coronary heart disease. 2. Short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335: 827-838.
11. Davis BA, Crook JE, Vestal RE et al (1979) Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. New England Journal of Medicine 310: 1273-1274.
12. *Department of Health and Social Security (1989) Report on Confidential Enquiries into Maternal Deaths in England and Wales 1982-84. London: HMSO.
13. Dieckmann WJ (1952) The Toxemias of Pregnancy, 2nd edn. St Louis, MO: Mosby.
14. Eliahou E Silverberg DS, Reisin E et al (1978) Propranolol for the treatment of hypertension in pregnancy. British Journal of Obstetrics and Gynaecology 85: 431-435.
15. *Friedman EA & Neff RK (1976) Pregnancy outcome as related to hypertension, edema and proteinuria. In Lindheimer MD, Katz AL & Zuspan FP (eds) Hypertension in Pregnancy. New York: Wiley, pp 13-22.
16. Gallery EDM & Gyory AZ (1997) Sublingual nifedipine in human pregnancy. Australian and New Zealand Journal of Medicine 27: 538-542.
17. *Gallery EDM, Ross MR & Gyory AZ (1985) Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. British Medical Journal 291: 563-566.
18. Gallery EDM, Saunders DM, Hunyor SN & Gyory AZ (1979) Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. British Medical Journal 1: 1591 -1594.
19. Hammond TG, Buchanan JD, Scoggins BA et al (1982) Primary hyperaldosteronism in pregnancy. Australian and New Zealand Journal of Medicine 12: 537-538.
20. Hou SH (1994) Pregnancy in women on haemodialysis and peritoneal dialysis. In Lindheimer MD & Davison JM (eds) Renal Disease in Pregnancy, Baillière's Clinical Obstetrics and Gynaecology, vol. 8, no. 2, chap. 14. London: Baillière Tindall.
21. Katz AL & Lindheimer MD (1984) Effect of pregnancy on the natural course of kidney disease. Seminars in Nephrology 4: 252-259.
22. Kincaid Smith P, Bullen M & Mills J (1966) Prolonged use of methyldopa in severe hypertension in pregnancy. British Medical Journal 27: 4-6.
23. Landesman R, Holze W & Scherr L (1955) Fetal mortality in essential hypertension. Obstetrics and Gynecology 6: 354-365.
24. Leather HM, Humphrey DM, Baker P & Chadd MA (1968) A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet 2: 488-489.
25. *Lindheimer MD & Katz AI (1994) Gestation in women with kidney disease: prognosis and management. In Lindheimer MD & Davison JM (eds) Renal Disease in Pregnancy, Baillière's Clinical Obstetrics and Gynaecology, vol. 8, no. 2, chap. 9. London: Baillière Tindall.
26. Mabie WC, Gonzales AR, Sibai BM et al (1987) A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstetrics and Gynecology 70: 328-333.
27. Maharaj B, Khedun SM, Moodley J et al (1995) Intravenous isradipine in the management of severe hypertension in pregnant and nonpregnant patients. American Journal of Hypertension 7: 61S-63S.
28. Page EW & Christianson R (1976) The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. American Journal of Obstetrics and Gynecology 125: 740-746.
29. Papiernik E & Kaminski M (1974) Multifactorial study of the risk of prematurity at 32 weeks of gestation. I. A study of the frequency of 30 predictive characteristics. Journal of Perinatal Medicine 2: 30-34.
30. Picker RH & Saunders DM (1976) A simple geometric method for determining fetal weight in utero with the compound grey scale ultrasonic scan. American Journal of Obstetrics and Gynecology 124: 493-496.
31. Plouin PF, Breart G, Maillard F et al (1988) Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. British Journal of Obstetrics and Gynaecology 95: 868-870.
32. Pollock CA, Gallery EDM & Gyory AZ (1990) Hypertension due to renal artery stenosis in pregnancy-the use of angioplasty. Australian and New Zealand Journal of Obstetrics and Gynaecology 30: 265-268.
33. Redman CWG, Beilin LJ & Bonnar J (1977) Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects. British Journal of Obstetrics and Gynaecology 84: 419-426.
34. *Redman CWG, Beilin LJ, Bonnar J & Ounsted MK (1976) Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 2: 753-756.
35. *Rey E, LeLorier J, Burgess E & Lange I (1997) Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. Canadian Medical Association Journal 157: 1245-1254.
36. Rubin PC, Butters L, Clark DM et al (1983) Placebo controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1: 431-434.
37. Schenker JG & Chowers I (1971) Phaeochromocytoma and pregnancy. Review of 89 cases. Obstetrics and Gynecology Survey 26: 739-742.
38. Sibai BM (1996) Treatment of hypertension in pregnant women. New England Journal of Medicine 335: 257-265.
39. Sibai BM & Anderson GD (1986) Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstetrics and Gynecology 67: 517-519.
40. Sibai BM, Abdella TN & Anderson GD (1983) Pregnancy outcome in 211 patients with mild chronic hypertension. Obstetrics and Gynecology 61:571-574.
41. Sibai BM, Akl S, Fairlie F et al (1990) A protocol for managing severe pre-eclampsia in the second trimester. American Journal of Obstetrics and Gynecology 163: 733-736.
42. *Silverstone A, Trudinger BJ, Lewis PJ et al (1980) Maternal hypertension and intrauterine fetal death in mid-pregnancy. British Journal of Obstetrics and Gynaecology 87: 457-460.
43. Simon N, Franklin SS, Bleifer KH et al (1972) Clinical characteristics of renovascular hypertension. Journal of the American Medical Association 220: 1209-1211.
44. Steyn DW & Odendaal HJ (1997) Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet 350: 1267-1271.
45. *Sturgiss SN, Dunlop W & Davison JM (1994) Renal haemodynamics and tubular function in human pregnancy. In Lindheimer MD & Davison JM (eds) Renal Disease in Pregnancy, Baillière's Clinical Obstetrics and Gynaecology, vol. 8, no. 2, chap. 1. London: Baillière Tindall.
46. Visser W & Wallenburg HCS (1995) A comparison between the haemodynamic effects of oral nifedipine and intravenous dihydralazine in patients with severe pre-eclampsia. Journal of Hypertension 13: 791-795.
47. Weitz C, Khouzami V, Maxwell K & Johnson JWC (1987) Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. International Journal of Gynaecology and Obstetrics 23: 35-38.
48. Wenger NK (1995) Hypertension and other cardiovascular risk factors in women. American Journal of Hypertension 8: 94S-99S.
49. Wenger NK, Speroff L & Packard B (1993) Cardiovascular health and disease in women. New England Journal of Medicine 329: 247-256.